Moderna in bid to double COVID-19 vaccine production to up to 3 billion doses in 2022 By: MarketWatch April 29, 2021 at 08:44 AM EDT The U.S. biotech also raised its manufacturing forecast for 2021 to 800 million to 1 billion doses. Read More >> Related Stocks: Biontech Se ADR Johnson & Johnson Moderna Inc Pfizer